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Our objective was to determine the effect of stress mediators such as
inflammatory cytokines and β adrenergic agonists on developing skeletal muscle. Fetal
sheep exposed to chronic maternal inflammation had decreased skeletal muscle glucose
oxidation rates when stimulated with insulin or TNFα. In addition, activation of Akt by
insulin was decreased after maternal inflammation when compared to controls and there
were not differences in skeletal muscle fiber type ratios between the two treatment
groups. This indicates that maternal inflammation does not affect overall oxidative
capacity in the developing fetus, but rather insulin signaling pathways are disrupted.
We sought to determine whether the metabolic response to β adrenergic and
insulin stimulation previously shown in mature skeletal muscle is a phenotypic trait
passed to the mature muscle from developing muscle stem cells. Bovine myoblasts were
differentiated in media containing either β1 adrenergic agonist +/- insulin or β2
adrenergic agonist +/- insulin. Glucose oxidation was increased in the myoblasts
simulated by β2 adrenergic agonist compared to myoblasts stimulated by β1 adrenergic
agonists suggesting that the β2 adrenergic agonist is more effective at enhancing glucose
metabolic efficiency than the β1 adrenergic agonist. Furthermore, we determined that
when stimulated by β2 adrenergic agonist and insulin, myoblasts had decreased glucose

oxidation rates compared to insulin alone. This is opposite of the effects seen in a similar
study conducted utilizing mature skeletal muscle, indicating that this response is not
necessarily derived from the muscle stem cell.
In a final study, we evaluated mitochondrial respiration rate in bovine myoblasts
from cows that had been classified as having either High or Low concentrations of
androstenedione (A4) in their follicular fluid. Calves born to cows classified as High A4
had increased weaning weights compared to calves born to cows classified as Low A4.
By performing a mitochondrial stress test using an XF-96 Seahorse Bioanalyzer, we were
able to measure cellular respiration. We hypothesized that myoblasts from the High A4
cows would have enhanced metabolic efficiency compared to the Low A4 cows.
However, we found no differences in mitochondrial oxidation rates among treatments but
did find a tendency (P = 0.1) for muscle stem cells from High A4 cows in the absence of
insulin and from Low A4 cows when insulin was present to have increased rates of
glycolysis. This indicates that the enhanced growth efficiency of the calves born to the
High A4 cows is likely due to a different biological mechanism.
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Chapter 1
Literature Review
Introduction
Intrauterine Growth Restriction
Placental insufficiency can be defined as a smaller or functionally stunted
placenta that limits the flow of nutrients from mother to fetus, leading to intrauterine
growth restriction (IUGR) (Molteni et al., 1978; Marconi et al., 2006; Alisi et al., 2011).
In the United States, IUGR is clinically defined as birth weight that falls below the 10th
percentile for an infant’s gestational age (Morrison, 2008). Infants born small for
gestational age (SGA) have an increased risk of developing metabolic syndrome later in
life, abnormal partitioning of dietary nutrients (Brodsky and Christou, 2004), and an
increase in perinatal and neonatal morbidity and mortality (Pollack and Divon, 1992;
Brodsky and Christou, 2004; Tuuli et al., 2011).
Impact of IUGR on Life Quality
Perinatal Morbidity and Mortality
Developmental adaptations due to IUGR have detrimental effects on infants
during the perinatal period. This includes increased risk of hypoglycemia, hypothermia,
chronic lung disease, and impairment of renal function (Chiswick, 1985). In addition,
many neonatal complications resulting from IUGR lead to death.
Childhood and Adult Disease
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IUGR also increases the risk of developing metabolic dysfunction, which can
substantially reduce the quality of life in humans because it leads to multiple health
issues. IUGR-induced metabolic dysfunction has been associated with an increased risk
of developing cardiovascular disease, type II diabetes, and predisposition to central
obesity; each of these factors increase the risk of morbidity and mortality (Gallagher et
al., 2011). Obese patients due to metabolic dysfunction can experience fatigue and an
increase in appetite stimulation, both of which contribute to further weight gain
(Gallagher et al., 2011). Furthermore, patients with central obesity have a higher risk of
developing fatty liver disease than patients with lower body fat (Grundy, 2000). Studies
have also shown that patients with obesity are more likely to develop certain cancers
including colon, breast, and prostate cancer (Grundy, 2000). Patients with metabolic
dysfunction require aggressive, long-term medical treatment in order to manage the risk
of chronic diseases such as cardiovascular disease and type II diabetes (Gallagher et al.,
2011). In fact, metabolic complications of diabetes costs an estimated $2.4 billion in
annual direct medical expenses (Kitabchi et al., 2009). The incidence of obesity and other
conditions related to metabolic dysfunction is increasing globally and is expected to
affect 40% of the world’s population by 2025 (Rinaudo and Wang, 2012). As many as
half of all clinical cases of metabolic disease are believed to be predisposed by IUGR
(Vonnahme, 2012). By understanding the underlying mechanisms, the incidence of
metabolic syndrome could be reduced in the future.
Impact of IUGR on Livestock Efficiency
In meat animals, a high proportion of muscle is critical because meat is the
profitable product (Irshad et al., 2013). However, IUGR results in a decrease in muscle
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growth due to adaptive fetal programming in response to restriction of nutrients. In fact,
nutrient restriction from early to mid-gestation has been shown to reduce muscle fiber
number in fetuses (Zhu et al., 2004). Furthermore, IUGR-induced low birth weight in
livestock species can lead to increased perinatal mortality due to reduced vigor
(Greenwood and Bell, 2002). Skeletal muscle makes up about 40% of the body’s mass
and plays a critical role in metabolism (DeFronzo et al., 1981). Consequently, as IUGRinduced low birth weight offspring mature, these animals develop a greater fat-to-muscle
ratio and have reduced lean muscle mass (Yates et al., 2012), leading to a decrease in
carcass quality, yield, and profit for the producer. Therefore, by understanding the
underlying mechanisms linking IUGR and poor muscle growth efficiency, carcass quality
and yield in low birth weight livestock could be improved, resulting in greater profit for
the producer.
Metabolic Syndrome
Metabolic syndrome is a human condition defined by the clinical diagnosis of
three out of the following five metabolic characteristics; insulin resistance, hypertension,
central obesity, increased triglyceride concentration, and decreased high density
lipoprotein concentration (Gallegher et al, 2011). This manuscript focuses on insulin
resistance, central obesity, and hypertension.
Insulin Resistance
Clinically defined as a reduction in biological response to insulin secretion
(Cefalu, 2001), insulin resistance is a known constituent of metabolic syndrome that is
often a result of stress-induced adaptive fetal programming (Hales and Barker, 2001;
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Gallagher et al., 2011). Insulin resistance manifests to type II diabetes when insulin is no
longer secreted at a high enough concentration to compensate for the lack of insulin
action due to reduced sensitivity (Reaven, 2005). Metabolic adaptations that contribute to
the development of insulin resistance in IUGR individuals include reduced skeletal
muscle mass and disruptions in insulin signaling pathways (Ozanne et al., 2005). Fetal
stress responses result from placental insufficiency and mediate nutritional thrift in order
to spare available nutrients for the most critical tissues to aid fetal survival. However,
when the IUGR individual is born into an environment where nutritional thrift is no
longer necessary and the mechanism has been programmed, insulin resistance is more
likely to develop due to typical calorie intake combined with thrifty energy expenditure
(Hales and Barker, 2001).
Central Obesity
Another characteristic of metabolic syndrome is central obesity. Obesity is
clinically defined as body mass index (BMI) >30 kg/m2 (Gallagher et al., 2011) as
opposed to clinically overweight which is defined as BMI >27.8 for males and >27.3 for
females (Van Itallie, 1985). Central obesity, or excessive truncal fat (Klein et al., 2007),
is indicative of adaptive fetal programming that disrupts metabolic function. IUGR-born
infants experience postnatal “catch-up” growth (Vaag, 2009), a period during early life in
which rapid weight gain occurs (Law et al., 2002). However, this has negative effects on
metabolic health later in life due to accelerated weight gain from fat deposition rather
than skeletal muscle accretion (Vaag, 2009). This is problematic in livestock production
as well, since animals develop greater fat-to-muscle body composition, resulting in lower
yield and meat quality (Irshad et al., 2013).
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Hypertension
Up to 85% of patients with metabolic dysfunction develop hypertension (Duvnjak
et al., 2008), which is clinically defined as blood pressure of ≥140/90 mmHg systolic
over diastolic, respectively (Gallagher et al., 2011). Hyperinsulinemia resulting from
insulin resistance elevates blood pressure, leading to sodium retention and volume
expansion (Duvnjak et al., 2008). Obese individuals tend to have increased blood
pressure, also leading to volume expansion and an increase in cardiac output (Grundy,
2000). Hypertension due to insulin resistance and obesity further manifests into vascular
damage (Duvnjak et al., 2008), cardiovascular disease, stroke, heart failure, and renal
failure (Grundy, 2000).

The “Thrifty Phenotype Hypothesis”
Adaptive Fetal Programming
About 25 years ago, David J.P. Barker first published his Thrifty Phenotype
Hypothesis which described the epidemiological link between individuals who are born
small for gestational age (SGA) and their increased risk of developing metabolic
syndrome later in life (Hales et al., 1991; Hales and Barker, 1992; Barker et al., 1993).
The Thrifty Phenotype Hypothesis suggests that the link between stress induced low birth
weight and the increased risk of developing metabolic syndrome results from fetal
adaptations to stress, resulting from a decrease in available nutrients that lead to
programmed alterations in glucose metabolism (Hales and Barker, 2001). Fetuses are
extremely responsive to their environment which can greatly influence their
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development, and developmental plasticity is reduced drastically after birth (Gluckman
and Hanson, 2004). Development of thrifty metabolic rates leads to more dietary
nutrients being directed toward storage as fat rather than being used for muscle accretion
or energy production. (Barker, 1998; Hales and Barker, 2001) Thrifty adaptive
programming is beneficial during gestation, however, it greatly increases the risk of
developing metabolic diseases in childhood and adulthood (Yates et al., 2012) including
metabolic syndrome (Barker et al., 1993). This is due to the inability for IUGR-born
individuals to cope with a different nutritional environment after birth (Rinaudo and
Wang, 2012). Since the postnatal diet is typically not limited, IUGR-born individuals
develop excess fat and not enough skeletal muscle due to restriction of nutrient and
oxygen transport during development (Bauer et al., 1998). Epidemiological studies
overwhelmingly support a link between IUGR and the increased risk of developing
metabolic syndrome (Barker, 1998; Hales and Barker, 2001). In fact, IUGR-born
offspring are 18-times more likely to develop metabolic syndrome than offspring born at
appropriate size for gestational age (Gatford et al., 2010). However, the underlying
mechanisms explaining the link between IUGR fetuses and the increased risk of
developing metabolic syndrome is still unknown (Hales and Barker, 2001; Vaag, 2009).
Maternal Stressors and Fetal Stress
The most common maternal stressors associated with IUGR in humans include
illness, nutritional deficiencies, and exposure to toxins during pregnancy (Rinaudo and
Wang, 2012) such as the use of drugs, smoking, or alcohol. The most common maternal
etiologies in livestock include environmental stressors such as heat, cold, or altitude
stress (Yates et al., 2011) as well as nutritional stress (Vonnahme, 2012). All of these
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stressors can cause placental stunting by reducing uterine blood flow (Bell et al., 1987)
(Figure1). Changes in placental vasculature caused by placental stunting limit the
umbilical vein and fetal artery’s ability to receive oxygen and nutrients (Greenwood and
Bell, 2002; Regnault et al., 2007; Vonnahme, 2012). This results in a chronically hypoxic
and hypoglycemic fetus later in gestation (Greenwood and Bell, 2002). As fetal
hypoxemia and hypoglycemia worsen, hypercatecholaminemia and hypoinsulinemia
develop in turn, since adrenal secretion of catecholamines work towards maintaining fetal
glucose supply by suppressing insulin secretion (Leos et al., 2010). The comprehensive
adaptations due to fetal stress are still unknown, but understanding the mechanisms
involved is the first step to finding a way to prevent or treat the effects of maternal stress
on the developing fetus.

Characteristics of IUGR Pathology
Sheep as a Model for Placental Insufficiency-Induced IUGR
Using animals as a model for biomedical research is advantageous because it
allows researchers to assess the effects of a particular stress applied over a certain time
period in a more controlled setting. Rodent and sheep models are the most common
models used for fetal biomedical research. The rodent model has advantages such as
lower cost and rapid gestation period. However, sheep physiology more closely
resembles human physiology, including metabolic function, nutrient transport, and
developmental milestones and critical periods (Barry and Anthony, 2008). Furthermore,
the ewe can be selected for one fetus as opposed to a litter of offspring such as rodents
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(Green et al., 2011; Rinaudo and Wang, 2012). Sheep also allow researchers to monitor
placental exchange as well as fetal physiology in utero in the conscious animal due to the
ability of the fetus to tolerate catheterization of fetal blood vessels that allows frequent,
real-time sampling from the conscious animal in utero. These characteristics make the
pregnant sheep a valuable model for human biomedical research (Barry and Anthony,
2008; Green et al., 2011).
The Role of Skeletal Muscle in IUGR Adaptations
Sufficient skeletal muscle mass plays an important role in glucose homeostasis
and the metabolic health of an individual. Skeletal muscle makes up ~40% of the body’s
mass (Yates et al., 2012) and accounts for greater than 80% of all insulin stimulated
glucose utilization (DeFronzo et al., 1981) and thus skeletal muscle plays a major role in
glucose homeostasis (Yates et al., 2012). However, placental insufficiency is known to
cause a reduction in fetal muscle mass due to the disruption of myogenesis (Yates et al.,
2012; Yates et al., 2014; Yates et al., 2016). This reduction in muscle mass carries into
adulthood and is known to have an impact on muscle strength (Inskip et al., 2007;
Ylihärsilä et al., 2007). Furthermore, there are strong correlations between IUGR,
insufficient muscle mass, and the development of insulin resistance, which leads to the
development of type II diabetes and the metabolic syndrome (Hales et al., 1991; Hales
and Barker, 2001). However, the origins of decreased muscle growth and metabolic
dysfunction in IUGR fetuses and IUGR-born offspring at the cellular level are not
presently understood, but the characterized pathologies are described in Figure 2.
Effects of IUGR on Skeletal Muscle Mass
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IUGR results in asymmetric growth due to disproportional reduction of muscle
mass and an increase in adipose tissue deposition after birth (De Blasio et al., 2007)
because skeletal muscle growth continues to be much slower in individuals born IUGR.
Ultrasonic measurements of IUGR fetuses show reduced muscle mass when compared to
non IUGR fetuses (Galan et al., 1999). Furthermore, IUGR individuals are not only likely
to have impaired muscle growth capacity, but also store more energy in adipose tissue as
a result of thrifty programming. Having less muscle mass is an advantage for these
fetuses because skeletal muscle is a major consumer of glucose, which the fetus requires
for normal development and function of neural, cardiac, and endocrine tissues (Klip and
Pâquet, 1990).
Myoblast/Myofiber Dynamics
During the early development of muscle, mononuclear muscle stem cells called
myoblasts proliferate, differentiate, and fuse into multinuclear myofibers (Yates et al.,
2012). During early gestational development, embryonic myoblasts fuse and form
primary myofibers which provide scaffolding for myoblast facilitated formation of
secondary myofibers (Yates et al., 2012; Brown, 2014) (Figure 3). Secondary myogenesis
occurs during mid-gestation. This involves proliferation of the fetal myoblasts which is
followed by expression of muscle regulatory factors (MRFs). Myofibers grow by
increasing in diameter and length, in a process known as hypertrophy. Hypertrophy is
mediated by activation and fusion of satellite cells with existing fibers and is the only
form of muscle growth after birth, since myofiber numbers can no longer increase (Allen
and Rankin, 1990). Myogenic markers such as Pax7, MyoD, and Myogenin can be used
to identify the stage at which myoblasts are at in their cycle. IUGR can have a negative
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impact on muscle development by disrupting this process, however the molecular
mechanisms remain to be understood. Pax7 is present in both fetal and postnatal skeletal
muscle (Hutcheson et al., 2009) and is expressed prior to differentiation (Zammit et al.,
2006). During proliferation, myoblasts express MyoD (Gillespie et al., 2009) and
continue to express as they exit the cell cycle and enter terminal differentiation (L'honore
et al., 2007). This leads into an increase in expression of Myogenin, the regulatory factor
that promotes fusion of myoblasts into myofibers (Edmondson and Olson, 1989).
Effects of IUGR on Skeletal Muscle Metabolic Rates
IUGR individuals have a higher risk of developing metabolic dysfunction than
non IUGR individuals. IUGR fetuses have altered metabolic rates because it allows them
to survive a harsh uterine environment. Insulin stimulated glucose uptake rate is greatest
in type I muscle fibers because this fiber type has the greatest insulin sensitivity (Lillioja
et al., 1987). IUGR fetuses are known to have diminished type I fiber to type II fiber
ratios, leading to unfavorable consequences in glucose homeostasis (Yates et al., 2016).
This insulin resistance leads to a loss of glucose homeostasis in adulthood (Ozanne et al.,
2005). Furthermore, a reduction in type I muscle fibers is known to reduce glucose
oxidation rates (Yates et al., 2012). Additionally, IUGR fetuses are characterized by
hyperlactatemia (Jones and Ritchie, 1978; Maeda and Koos, 2009). Increased
concentrations of catecholamines and acute hypoxemia during fetal stress causes a shift
in metabolism from aerobic to anaerobic metabolism, resulting in increased lactate
production (Limesand et al., 2007; Yates et al., 2012; Brown et al., 2015).
Type I Muscle Fibers Are Most Impacted by IUGR
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In healthy individuals and livestock (Wilson et al., 1992), there is a natural shift
from type II to type I muscle fibers throughout late gestation and in the first few months
of life, however, IUGR may inhibit this shift and thus decrease metabolic plasticity
(Yates et al., 2016). IUGR is predictive of a disproportional decrease in skeletal muscle
mass throughout life. This is especially evident in muscles that are composed of type I
muscle fibers, including soleus (De Blasio et al., 2007). Type I muscle fibers generally
have the highest oxidative capacity, larger amounts of GLUT4, increased β adrenergic
receptors which make them more likely to be impacted by the chronic stress response
(Yates et al., 2012), and are especially prone to insulin insensitivity (Yates et al., 2016).
Thus, greater nutrient sparing results when the type I muscle fiber proportion is
disproportionately reduced relative to type II. Muscle fiber number is set before birth in
most species, and there is no increase in muscle fiber number once an individual is born
(Zhu et al., 2006; Yates et al., 2012; Brown, 2014). It is thought that nutrient restriction to
the muscle fibers is linked to the predisposition of individuals born as a result of IUGR to
the development of type II diabetes (Zhu et al., 2006).
Reduced Insulin Sensitivity
IUGR causes a reduction in the offspring’s insulin sensitivity, resulting in insulin
resistance and eventually type II diabetes (Limesand et al., 2007). Insulin resistance is the
metabolic state wherein peripheral tissues, especially skeletal muscle, have a reduced
response to the effects of insulin and therefore glucose uptake rate by the cells is
diminished (Dunlop et al., 2015). Skeletal muscle is most impacted by reduced insulin
sensitivity because it accounts for greater than 80% of the body’s insulin stimulated
glucose utilization (DeFronzo et al., 1981). Insulin acts by binding to its tyrosine kinase
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receptor on the cell surface, which ultimately promotes translocation of GLUT4 to the
surface of the cell. Autophosphorylation of tyrosine kinase, which catalyzes the
phosphorylation of IRS1 and in turn Akt, results in the regulation of glucose uptake
(Saltiel and Kahn, 2001). Previous studies have shown that the expression of the insulin
receptor is actually increased in IUGR fetuses (Limesand et al., 2007), which is thought
to be a compensatory mechanism for the decrease in circulating fetal insulin. However,
expression of the receptors was not different in IUGR versus normal birth weight
offspring, indicating that insulin resistance later in life results from a downstream defect
of the receptor which alters the function of GLUT4 (Dunlop et al., 2015).

Skeletal Muscle Glucose Homeostasis
IUGR Blood Glucose Concentrations
Glucose is the primary energy substrate utilized by the fetus for normal growth
and metabolism (Hay, 2006) and thus the latter is dependent on fetal plasma glucose
concentration. Skeletal muscle adapts in response to glucose concentration (Yates et al.,
2016). In a chronically hyperglycemic condition, there is a reduction in GLUT4 as well
as other insulin signaling components (Limesand et al., 2007) in skeletal muscle which
correlates with the development of insulin resistance later in life (Hay, 2006; Dulloo,
2008). A reduction in GLUT4 transporters in skeletal muscle cells reduces insulin
sensitivity, resulting in a continuous state of hyperglycemia in adults (Dunlop et al.,
2015). In hypoglycemic conditions, insulin responsive tissues are known to adapt using
mechanisms such as increased insulin action and regulation of glucose transporter
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concentrations that promote glucose utilization (Limesand et al., 2007). However,
glucose transporter concentrations are not different between IUGR and normal
birthweight individuals later in life (Dunlop et al., 2015).
Glucose Uptake and Metabolism
Glucose uptake and glucose oxidation play independent roles in an individual’s
metabolic rate. Glucose uptake is when glucose molecules are brought into the cells by
insulin sensitive GLUT4 and other GLUT transporters (Saltiel and Kahn, 2001; Leney
and Tavaré, 2009). There are multiples types of GLUTs that have different specificities,
kinetic properties, and expression profiles (Wood and Trayhurn, 2003). However,
GLUT4 is insulin stimulated (Abel et al., 2001; Saltiel and Kahn, 2001). A wide variety
of metabolic pathways follow glucose uptake such as glycolysis. Pyruvate is synthesized
during this process. Pyruvate formed during glycolysis is oxidized to acetyl-CoA which
then enters the citric acid cycle (Nelson and Cox, 2008, pg. 616). Insulin-stimulated
glucose uptake and oxidation are presumed to be proportional, however, the presence of
stress factors such as inflammatory cytokines may alter these metabolic functions
(Cadaret et al., 2017b). In fact, IUGR fetuses are known to have lower glucose oxidative
metabolism (Yates et al., 2012). By performing glucose uptake and oxidation studies,
researchers are able to further their understanding of how acute and chronic stress factors
change metabolic rates. Increased circulating catacholamines and decreased insulin
concentrations in IUGR fetuses in concert contribute to hyperlactatemia which may be
caused by reduced glucose oxidation in the skeletal muscle in order to spare glucose and
oxygen for vital tissues such as the brain. Prolonged durations of skeletal muscle nutrient
and oxygen deprivation causes a metabolic shift. Therefore, adaptations to fetal
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catecholamine concentrations in utero may explain this shift from oxidative metabolism
to anaerobic glycolysis (Yates et al., 2012) (Figure 4). Furthermore, anaerobic glycolysis
in meat producing animals is unfavorable due to a decrease in pH caused by lactate
production which is known to effect meat quality attributes including water holding
capacity, color, and juiciness (Andersen et al., 2005).

Inflammatory Component of the Stress Response
Introduction to Cytokines
Pro-inflammatory cytokines such as IL-6 (Interleukin-6) and TNFα (Tumor
Necrosis Factor) play a critical role in the inflammatory response of IUGR (Bartha et al.,
2003). These cytokines are predominantly produced by macrophages and participate in
the up-regulation of inflammatory reactions (Zhang and An, 2007). In addition to proinflammatory cytokines, there is another group of cytokines known as the antiinflammatory cytokines including IL-1, IL-4, IL-10, IL-11, and IL-13. (Zhang and An,
2007). Pro-inflammatory cytokines are associated with skeletal muscle degeneration
during states of chronic stress (Späte and Schulze, 2004), while anti-inflammatory
cytokines are immunoregulatory molecules that regulate the response of the proinflammatory cytokines by inhibiting their function. The inflammatory and metabolic
systems are closely linked which is advantageous under certain conditions. For example,
an organism may need to redistribute its energy sources during an inflammatory response
(Dionne et al., 2006). Furthermore, the pro-inflammatory cytokine TNFα is highly
expressed in adipose tissue (Hotamisligil et al., 1993) and also plays a role in disrupting
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insulin signaling pathways when activated (Uysal et al., 1997). Elevated concentrations
of inflammatory cytokines under stressful conditions mediate proteolysis so that available
amino acids provide fuel to the liver rather than skeletal muscle, resulting in an inhibition
of muscle growth (Klasing and Johnstone, 1991). Therefore, inflammatory cytokines play
major roles in both metabolism and muscle growth in IUGR individuals.
Cytokine Signaling
The major cytokine signaling pathways have been reviewed in detail by O’Shea et
al. 2002 (Figure 5). The cytokine signaling pathway begins when inflammatory cytokines
bind to homodimeric or heterodimeric receptors. These receptors bind to Janus kinases
(JAKs) which phosphorylate the cytokine receptors. This phosphorylation allows signal
transducers and activators of transcription (STAT) to bind. STAT is then phosphorylated
and translocated to the nucleus of the cell where it binds to DNA and functions to
regulate gene expression. More specifically, TNFα activates the transcription factor
NFκB (Van Antwerp et al., 1996). Furthermore, cytokines can be regulated by
stimulation of the proteins SOCS. SOCS can then inhibit cytokine signaling by binding to
and inhibiting JAK/STAT.
Long Term Effects of Inflammatory Cytokines
The combined increased levels of IL-6 and IL-1β in an acute-phase response
increases the risk of developing type II diabetes three-fold (Spranger et al., 2003). Studies
have shown that chronically increased levels of IL-6 are associated with an increased risk
of developing type II diabetes (Pickup and Crook, 1998). Both IL-6 and IL-1β act on the
liver to produce characteristics of metabolic syndrome such as insulin resistance (Pickup
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and Crook, 1998), and skeletal muscle which causes atrophy during states of chronic
stress (Späte and Schulze, 2004). In addition, studies have shown increased levels of
amniotic (Kupferminc et al., 1994) inflammatory cytokines in cases of IUGR (Heinig et
al., 2000; Holcberg et al., 2001; Alisi et al., 2011). Elevated concentrations of
inflammatory cytokines in amniotic fluid have been linked to irregular immune
activation, leading to the pathophysiology of IUGR (Bartha et al., 2003). Studies suggest
that administration of bacterial lipopolysaccharide (LPS) endotoxin to induce maternal
inflammation in the second half of pregnancy reduced fetal weight significantly in rats
when compared to control dams treated with saline (Cadaret et al., 2017a), suggesting
that systemic maternal inflammation is impacting fetal weight by causing fetal
inflammation. In conclusion, maternal inflammation correlates with a decrease in
placental growth, particularly reduced thickness, and a decrease in length and area,
(Cotechini et al., 2014), which is known to cause smaller postnatal body size and
development of metabolic deficiencies later in life (Barker et al., 2010). The chronic
effects of pro-inflammatory cytokines are complex and are linked to the development of
insulin resistance (Marette et al., 2014), which ultimately manifests in metabolic
syndrome (Dandona et al., 2005).
Nonsteroidal Anti-Inflammatory Drugs and Pregnancy
Fetal exposure to inflammatory cytokines during gestation leads to metabolic
adaptations that can be detrimental after birth and into adulthood such as insulin
resistance and obesity (Pickup and Crook, 1998). NSAIDS (nonsteroidal antiinflammatory drugs) are used to treat inflammatory responses by inhibiting
cyclooxygenase (Østensen, 1996). Pregnant women are currently discouraged from
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taking NSAIDS. The use of NSAIDS during pregnancy is thought to cause miscarriage
(Li et al., 2003), intracranial hemorrhaging (Rumack et al., 1981), and renal failure
(Cantor et al., 1980). However, there have been minimal studies conducted on fetal
exposure to NSAIDS (van Gelder et al., 2011).

Elevated Steroid Concentrations and Gestation
Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 5-10% of
females of reproductive age (Franks, 1995). Females with PCOS experience ovarian
cysts, irregular menstrual cycles, and hyperandrogenism. Furthermore, PCOS is
accompanied by metabolic deficiencies such as insulin resistance and obesity (Faloia et
al., 2004). Elevated androgen levels seen in females with PCOS remain even during
pregnancy (Sir-Petermann et al., 2002). Androgens including testosterone can reduce
fetal and newborn growth in offspring from females with hyperandrogensim (Carlsen et
al., 2006).
Effects of Elevated Androgen Levels on Fetal and Newborn Growth
Exposure to excess androgens during critical periods of gestation can lead to
reduced birth weight (Carlsen et al., 2006) and metabolic deficiencies in offspring (Smith
et al., 2009). Female fetuses exposed to elevated testosterone during gestation have
impaired insulin secretion and increased adiposity later in life (Eisner et al., 2000). In
ewes, prenatal exposure to elevated testosterone levels causes IUGR (Steckler et al.,
2005). Recent studies indicate that exposure to androgens during fetal development
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induces metabolic deficits which may be due to programming of metabolic pathways
(Abbott et al., 2005).
Conclusion
It is well known that maternal stress has adverse effects on the development of a
fetus’s muscle growth and metabolic function leading to the development of metabolic
syndrome later in life. Evidence suggests that maternal inflammation is causing fetal
inflammation either directly or indirectly by causing placental insufficiency. Pregnant
women are currently discouraged from taking NSAIDS because it has been shown to
cause unfavorable neonatal outcomes (Cantor et al., 1980; Rumack et al., 1981; Li et al.,
2003). However, the aim of current research is to understand whether chronic
inflammation during pregnancy is more damaging to the fetus than the effects of
NSAIDS that treat chronic inflammation. By understanding the underlying mechanism
causing fetal inflammation, we will be able to better address the pathophysiology and
prevention of long-term metabolic diseases in humans and livestock, improving quality of
life. More specifically directed towards livestock production, increased meat quality and
profit for the producer can be achieved.
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Figure 1. Maternal stressors lead to adaptive fetal changes in growth and metabolism
by stunting the placenta. Placental insufficiency ultimately leads to fetal inflammation
by causing hypoxemia, hypoglycemia, hypercatacholaminemia, and hyperinsulinemia.
The perinatal effects of these factors include hypertension, asymmetric growth, and
insulin resistance.
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Figure 2. During conditions of placental insufficiency, fetal muscle mass is greatly impacted.
A reduction in fetal muscle mass will ultimately lead to an increased risk of developing
metabolic deficiencies later in life due to skeletal muscle being a primary tissue for glucose
utilization.
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Figure 3. Activated myoblasts will proliferate, differentiate, and fuse and with myofibers.
Each of these stages is characterized by expression of specific muscle regulatory factors
(MRF) transcription factors.
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Figure 4. Hypercatecholaminemia and hypoxemia experienced during fetal stress causes a
metabolic shift from aerobic glycolysis to anaerobic glycolysis, leading to excess lactate
production.
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Figure 5. Inflammatory cytokine signal transduction pathway.
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Chapter 2
Maternal inflammation in the pregnant ewe at 0.7 gestation impairs glucose
oxidation in fetal skeletal muscle near term
Abstract. Placental insufficiency caused by maternal stress during gestation is known to
decrease birth weight and increase the risk of offspring developing metabolic deficiencies
such as insulin resistance and obesity. However, the underlying mechanisms remain to be
understood. Our objective was to determine if chronic maternal stress impairs subsequent
glucose metabolism rates in fetal sheep near term. Pregnant ewes were treated with saline
(controls) or bacterial endotoxin (LPS) every 3rd day from day 100-115 of gestation (term
= 150 days) to induce systemic inflammation. On gestational day 125, ewes were
euthanized and fetal soleus muscle was isolated tendon-to-tendon and split longitudinally.
To determine glucose uptake and glucose oxidation rates, soleus strips were incubated in
KHB (Krebs Henseleit Buffer) that was un-spiked (basal) or spiked with either insulin or
TNFα. In addition, Akt phosphorylation in extensor digitorum longus muscle samples
was determined by western immunoblot analysis and Myosin heavy chain (MyHC)
content was determined using electrophoresis. Furthermore, fiber type numbers and sizes
were determined from fetal semitendinosus sections by immunohistochemistry. In
primary fetal soleus muscle, glucose uptake was not different between control and
maternal inflammation fetuses under basal, insulin-stimulated, or TNFα-stimulated
conditions. However, insulin-stimulated glucose oxidation and TNFα-stimulated glucose
oxidation were both greatly decreased (P < 0.05) in chronically stressed fetal muscle
compared to controls. In addition, Akt phosphorylation was decreased (P < 0.05) after
maternal inflammation when compared to controls. However, there were not differences
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in MyHC content or skeletal muscle fiber number but Type IIx muscle fiber area was
decreased (P < 0.05) after maternal inflammation when compared to controls. Our
findings indicate that glucose metabolism in fetuses is impaired after chronic maternal
inflammation which explains in part how stress-induced IUGR caused by maternal
stressors increases the risk of insulin resistance in offspring. Phosphorylation of Akt in
insulin cultures is diminished which indicates that decreased Akt phosphorylation is the
mechanism causing impaired glucose metabolism rather than differences in skeletal
muscle fiber proportions.
Introduction
Infants born small for gestational age as a result of IUGR are known to be at an
18-fold greater risk for developing metabolic syndrome later in life (Gatford et al., 2010).
Reduction in muscle mass contributes to reduced size at birth, as less muscle is
advantageous for fetuses developing in a harsh uterine environment because limited
nutrients can be redirected to more vital brain and heart tissues (Hales and Barker, 2001).
Skeletal muscle accounts for greater than 80% of insulin-stimulated glucose metabolism
(DeFronzo et al., 1981) and therefore plays a major role in glucose homeostasis (Yates et
al., 2012).
Insulin is known to increase glucose uptake in skeletal muscle by binding to its
tyrosine kinase receptor and activating a signaling cascade that ends with the GLUT4
transporter being translocated to the cell membrane, where it facilitates glucose transport
into the cell. Akt phosphorylation is a critical step in the insulin signaling pathway that
contributes to many of insulin’s effects on the cell (James et al., 1988). In this study, we
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determined whether changes in glucose metabolism coincide with changes in Akt
phosphorylation rates, which could help explain reduced insulin sensitivity.
Inflammatory cytokines such as TNFα and IL-6 acutely stimulate skeletal muscle glucose
oxidation similarly to insulin, despite disrupting insulin signaling (Cadaret et al., 2017b).
However, chronic exposure to inflammation may reduce sensitivity to cytokines. We
hypothesize that fetal muscle that has been chronically inflamed due to maternal
inflammation during the third trimester of pregnancy will become less responsive to the
stimulatory effects of inflammatory cytokines, which can ultimately lead to the
development of insulin resistance (Pickup and Crook, 1998; Spranger et al., 2003). We
speculate that stressed fetuses with reduced muscle mass will have a decrease in glucose
uptake and oxidation when compared to controls.
Materials and Methods
Animals. The following experiments were approved by the Institutional Animal
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by
the American Association for Accreditation of Laboratory Animal Care. Animals used
for this study included thirteen timed-bred Polypay ewes carrying ultrasound-verified
twin pregnancies. Polypay ewes carrying twins received an IV injection of sterile saline
(Controls; n = 8) or 0.1 μg/kg BW of bacterial lipopolysaccharide (LPS; n = 5) from E.
coli O55:B5 (Sigma-Aldrich, St. Louis, MO) every third day from day 100 to 115 of
gestation (term = 150 days) (Figure 1).
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Glucose Uptake. Soleus muscle (100-500 mg) was utilized for this experiment
due to its increased type I muscle fiber ratio, thus having high oxidative capacity. The
muscle was isolated tendon to tendon during necropsy from fetal sheep at 125 dGA. Preincubation, wash, and incubation media were spiked with the following treatments: none
(basal), insulin (5 mU/ml Humulin-R), or TNFα (20 ng/ml hTNFα). All additives were
purchased from Sigma-Aldrich (St. Louis, MO). Muscle strips were incubated at 37º C
for 20 minutes in treatment spiked KHB with 1 mM [3H]2-deoxyglucose and 39 mM
[14C] mannitol. Muscle strips were removed and washed thrice in ice-cold PBS, weighed,
and lysed in 2 M NaOH at 37º C for 1 hour. Lysate was mixed with scintillation fluid and
specific activity of [3H] and [14C] was measured. Specific activity of media was also
determined.
Glucose Oxidation. Muscle strips were placed in sealed dual-well chambers and
incubated at 37º C for 2 hours in treatment-spiked KHB with 5 mM [14C-U] D-glucose. 2
M NaOH was put into the adjacent wells to collect 14CO2. After the 2 hour incubation, the
chambers were cooled at -20º C for 2 minutes. 2M HCl was injected into the media
through the rubber seal. Chambers were placed at 4º C for 1 hour. Chambers were opened
and muscle strips were washed and weighed. The NaOH was collected and mixed with
scintillation fluid to determine the specific activity of 14CO2. Specific activity of media
was also measured.
Myosin heavy chain electrophoresis. Fetal extensor digitorum longus muscle
(100-500 mg) was used due to its high oxidative capacity. The muscle was split
longitudinally and muscle strips were incubated in insulin-spiked KHB for 20 minutes,
snap frozen, and stored at -80ºC. The muscle strips were homogenized in 200 µl of RIPA
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buffer containing manufacturer recommended concentrations of Halt Protease and Halt
Phosphatase Inhibitor Cocktails (Thermo Fisher). Homoginates were sonicated and
centrifuged (2,500 x g; 10 minutes). Supernatant was collected and total protein
concentrations were determined by Pierce BCA Assay (Thermo Fisher). Samples were
then incubated at room temperature for 10 minutes., heated at 70ºC for 10 minutes.,
combined with Bio-Rad 4X Laemmli Sample Buffer (Bio-Rad, Hercules, CA) to a 1X
concentration, and loaded onto a separating gel at 15 µg/well. Myosin heavy chain
isoforms were then separated by SDS-Page. The separating gel consisted of 35%
glycerol, 9% acrylamide/bisacrylamide (50:1), 230mM Tris (pH 8.8), 115mM glycine,
0.4% SDS, 0.5% TEMED, and 0.1% APS. The gel was poured between plates, overlaid
with water, and allowed to polymerize for 10 minutes. After polymerization, water was
removed using blot paper. Stacking gel consisted of 47% glycerol, 6%
acrylamide/bisacrylamide (50:1), 110mM Tris (pH 6.7), 6mM EDTA, 0.4% TEMED, and
0.1% APS. This gel was poured on top of the polymerized separating gel. The comb was
inserted and gel was allowed to polymerize for 15 minutes. Protein samples were
prepared by combining 15 µg of protein with 4X sample buffer (to 1X). Samples were
incubated at room temperature for 10 minutes then put on a dry bath at 70ºC for 10
minutes. To run the SDS-page, the comb was removed and wells were rinsed with water,
wells were loaded at 15 µg/well, and gel was run at 100 volts for 30 hours at 4ºC. After
electrophoresis, the SDS-Page was washed and stained with GelCode Blue Stain Reagent
overnight. Samples were then imaged using an Odyssey infrared imaging system (LICOR Biosciences, Lincoln, NE). Myosin heavy chain I and myosin heavy chain II bands
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were measured by densitometry (Image Studio Lite Ver 5.0; LI-COR) and normalized to
total MyHC protein content.
Western Immunoblot. The activation of Akt was estimated by the proportions of
phosphorylated to total Akt protein as previously described (Cadaret et al., 2017b), with
minor modifications. Phosphorylated Akt and total Akt protein concentrations were
determined in fetal extensor digitorum longus muscle strips that were incubated in
insulin-spiked KHB for 20 minutes, snap frozen, and stored at -80ºC. Muscle strips (100500 mg) were homogenized in 200 µl of radioimmunoprecipitation buffer containing
manufacturer-recommended concentrations of Protease and Phosphate Inhibitor (Thermo
Fisher, Carlsbad, CA). Homogenates were sonicated and centrifuged (14,000g for 5
minutes at 4ºC), then supernatant was collected. Total protein concentrations were
determined by Pierce BCA Protein Assay Kit (Thermo Fisher). Protein samples were
boiled for 5 minutes. at 95ºC in BioRad 4X Laemmli Sample Buffer (BioRad, Hercules,
CA) then separated by SDS-polyacrylamide. Protein samples were diluted into 4X
sample buffer (to 1X) and incubated at room temperature for 10 minutes. Samples were
then put in a dry path at 70ºC for 10 minutes. Protein was loaded for electrophoresis and
gel was run at 100 volts for 30 minutes at 4ºC. Gels were transferred to polyvinylidene
fluoride low florescence membranes (BioRad) which had been incubated in Odyssey
block solution (Li-Cor Biosciences, Lincoln, NE) for 1 hour at room temperature and
washed with 1X TBS-T (20mM Tris-HCl + 150mM NaCl + 0.1% Tween 20).
Membranes were then incubated with one of the following rabbit antibodies diluted in
Odyssey block solution + 0.05% Tween-20: anti-phospho-Akt (Cell Signaling, Danvers,
MA) (1:2000) for 1 hour at room temperature or anti-Akt (9272) (1:1000) at 4ºC

30

overnight. An IR800 goat anti-rabbit IgG secondary antibody (1:10,000) diluted in
Odyssey block solution with 0.05% Tween-20 and 0.01% SDS was applied for 1 hour at
room temperature. Blots were scanned on an Odyssey Infrared Imaging System and
analyzed with Image Studio Lite Software (Li-Cor). For each protein of interest,
phosphorylation rates were estimated by the proportions of phosphorylated protein to
total protein.
Immunohistochemistry. Isolated semitendinosus muscle was fixed in 4% PFA for
48 hours, 30% sucrose for 24 hours, and 50:50 OCT: 50% sucrose mixture for 24 hours.
A cross section of muscle was embedded in OCT (Fisher HealthCare, Houston, TX) and
stored at -80ºC. Muscle tissue was then sectioned by cryostat and mounted on glass
microscope slides at 8µm, two cross sections per slide, and stored at -80ºC. Before
staining, slides were dried in an Isotemp Oven (Thermo Scientific, Waltham, MA) at
37ºC for 30 minutes. and rehydrated in PBS+ (PBS with 0.5% Triton-X-100) 3 x 5
minutes each. Slides were fully submerged in citric acid (10mM) and microwaved at 40%
power 4 x 5 minutes each and cooled for about 1 hour and submerged in PBS+ 3 x 5
minutes each. 50µl of NEN blocking agent (0.5% NEN) was used to cover each cross
section and each tissue was overlaid with Parafilm (Bemis, Neenah, WI) and incubated
for 1 hour at room temperature in a humidified container. One of the following primary
antibodies diluted in PBS + 1% BSA were added to tissue sections to detect myosin
heavy chain I or IIx: 0.2 µg/ml BA-D5 or 2 µg/ml 6H1, respectively Each tissue was also
co-stained for Desmin (1:300, Sigma). Slides were incubated overnight at 4ºC in a
humidified container. On the second day, slides were washed in PBS+ 3 x 5 minutes.
each. One of the following secondary antibodies diluted in PBS + 1% BSA were added to

31

tissue sections to detect myosin heavy chain I or IIx: 1:2000 Alexa Fluor 594 IgG or
1:2000 594 IgM (Cell Signaling, Danvers, MA), respectively. Slides were incubated for 2
hours at room temperature in a humidified container. Slides were washed for 5 minutes in
PBS+ then submerged in double distilled H2O 2 times for 5 minutes each. 100µl per slide
of DAPI (1:1000 in double distilled H2O) (Sigma) was added and slides were incubated
at room temperature for 4 minutes. Slides were washed in double distilled H2O for 5
minutes and then 250 µl of 0.3% Sudan Black (Fisher Scientific, Waltham, MA) was
added to each slide for 20 minutes at room temperature in a humidified container. Slides
were washed in double distilled H2O 3 x 5 minutes each. Slides were then coverslipped
with 100µl of Tris buffered mounting media (0.1M). Staining was visualized using
Olympus CellSense Software to determine proportions and average cross-sectional areas
of positively-stained fibers within muscle sections.
Statistical Analysis. Data were analyzed by ANOVA using the GLM procedure of
SAS (SAS Institute, Cary, NC). Glucose uptake and glucose oxidation data were
analyzed as two different experiments, each with its own basal, insulin, and TNFα
conditions. Two separate muscle strip from each fetus was exposed to each condition in
the experiment and averaged. Fetus was the experimental unit (control, n=8, maternal
inflammation, n=6). Glucose metabolic rates are normalized to muscle strip mass and
presented as percentage change from basal conditions. Data are presented and means ±
standard error.
Results
Glucose Uptake. Incubation with insulin increased (P < 0.05) glucose uptake in
fetal soleus muscle from both control and after maternal inflammation by ~30% and
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~26%, respectively (Figure 2). Moreover, glucose uptake rates in fetal muscle strips
incubated with TNFα was increased (P < 0.05) in both control and after maternal
inflammation by ~48% and ~28% from basal conditions, respectively, and was not
different from muscle incubated with insulin for either treatment group.
Glucose Oxidation. An interaction (P < 0.05) was observed between maternal
treatment and incubation media for glucose oxidation (Figure 3). Incubation in media
spiked with insulin increased (P < 0.05) glucose oxidation in fetal muscle from both
treatment groups, but the increase was greater (P < 0.05) in fetal muscle from control
fetuses than after maternal inflammation by ~19%. Moreover, when muscle from control
fetuses was incubated with TNFα, glucose oxidation was ~69% greater (P < 0.05) than
when incubated under basal conditions but less by ~12% (P < 0.05) than when incubated
with insulin. Conversely, when muscle from fetuses after maternal inflammation was
incubated with TNFα, glucose oxidation rates did not increase above basal conditions.
Akt Phosphorylation. Insulin stimulated phosphorylation of Akt was decreased (P
< 0.05) in the fetal muscle strips after maternal inflammation compared to controls and
was not different from muscle incubated under basal conditions (Figure 4). Furthermore,
there was no difference in Akt phosphorylation between fetal muscle strips from either
treatment stimulated with TNFα compared to basal.
Myosin Heavy Chain Expression. Proportions of Type I fibers and Type IIx fibers
were identified by MyHC staining (Figure 5). There were no differences in fiber type
numbers between fetal semitendinosus from control fetuses and after maternal
inflammation for Type I or Type IIx fibers (Figure 6). Furthermore, there was a decrease
(P < 0.05) in Type IIx fiber area by ~57% after maternal inflammation compared to
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control fetuses (Figure 7). In addition, there was no difference in myosin heavy chain
ratios between control and chronically stressed fetuses (Figure 8).
Discussion
In this study, we show that insulin responsiveness of glucose oxidation is
impaired in fetal skeletal muscle after chronic maternal inflammation. This helps to
explain how IUGR born individuals are at an increased risk of developing metabolic
diseases, despite the fact that capacity for insulin-stimulated glucose uptake in fetal
muscle was not affected by chronic maternal inflammation. Moreover, stimulation of
glucose oxidation by inflammatory cytokines was diminished by fetal adaptations to
chronic maternal inflammation, even after inflammation had been alleviated.
Additionally, insulin-stimulated Akt activation was impaired in fetal skeletal muscle after
chronic maternal inflammation, which shows that disruptions in insulin signaling are
contributing to impaired glucose oxidation. Furthermore, we determined that reduced
glucose oxidative capacity was not attributable to changes in fiber type proportions as
these were not different between treatment groups. Interestingly, maternal inflammation
did lead to smaller Type IIx fibers but not Type I fibers. These findings may help to
explain previous findings showing that chronic inflammation during fetal development
increases the risk of developing insulin resistance later in life (Hotamisligil et al., 1993).
This study also shows exposure of fetal skeletal muscle to chronic inflammation
inhibits TNFα-stimulated glucose oxidation, which was observed in controls. Our
previous studies show that acute exposure to inflammatory cytokines increases glucose
oxidation in muscle even in the absence of insulin (Cadaret et al., 2017b). However, the
present study shows that chronic exposure to inflammation during fetal development
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decreases this metabolic response and that subsequent stimulation by cytokines does not
produce greater glucose oxidation. Thus, the acute benefit of this metabolic regulator is
lost even though other changes associated with cytokines such as insulin insensitivity
likely still occur.
Skeletal muscle fiber type ratios were not affected by chronic maternal
inflammation. While fiber type number was not different between treatments, the area of
Type IIx fibers was decreased after maternal inflammation compared to controls. This
indicates that there is no difference in the inherent oxidative capacity between skeletal
muscle of the two groups of fetuses per se, but rather a reduced capacity to respond to
insulin. Insulin-stimulated fetal skeletal muscle showed a reduction in activation of Akt
after maternal inflammation. This shows that the impaired response to insulin is
associated with chronic stress at least in part due to inflammatory adaptations. Thus,
impairment of downstream hubs such as Akt may be major contributors to the decrease in
glucose oxidation in chronically stressed fetuses rather than diminished proportions of
Type I oxidative fibers.
In conclusion, our study shows that fetuses exposed to chronic maternal
inflammation develop decreased insulin-stimulated glucose oxidation rates despite
normal oxidative capacity as indicated by fiber type proportions. Rather, Akt activation
by insulin is substantially decreased by chronic maternal inflammation. This suggests that
the decreased oxidation rate stems from adaptive impairment in insulin signaling.
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Figure 1. Polypay ewes carrying twins received an IV injection of sterile saline
(Controls; n = 8) or 0.1 μg/kg BW of bacterial lipopolysaccharide (LPS; n = 5) every
third day from day 100 to 115 of gestation.
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Figure 2. Glucose uptake in fetal soleus muscle strips after maternal inflammation
during 20 minute incubations spiked with one of the following treatments: No additive
(basal), Insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα), respectively. a,b
means with differing subscripts differ (P<0.05).
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Figure 3. Glucose oxidation in fetal soleus muscle strips after maternal inflammation
during 120 minute incubations spiked with one of the following treatments: No
additive (basal), Insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα),
respectively. a,b,c means with differing subscripts differ (P<0.05).
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Figure 4. Akt phosphorylation in fetal extensor digitorum longus muscle after chronic
maternal inflammation stimulated by one of the following treatments: No additive (basal),
insulin (5mU/ml Humulin-R), or TNFα (20ng/ml hTNFα), respectively. a,b means with
differing subscripts differ (P<0.05).
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Figure 5. Immunostaining for fiber type in fetal semitendinosus muscle.
Representative micrographs are depicted for control and after maternal inflammation
semitendinosus cross sections (8 µm). Sections were stained for myosin heavy chain
isoforms (red) and counterstained for desmin (green). Bar = 100 µm.
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Figure 6. Muscle fiber-type proportions. The percentages of total fibers are presented
for control and chronically stressed fetal semitendinosus muscle sections. Type I and
Type IIx fibers were determined by immunohistochemistry. All sections were
counterstained for desmin to determine total fiber numbers.
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Figure 7. Muscle fiber cross-sectional areas presented for control and chronically
stressed fetal semitendinosus muscle sections. Type I and Type IIx fibers were
determined by immunohistochemistry. All sections were counterstained for desmin to
determine total fiber numbers. *Means differ (P < 0.05) between treatment groups.
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Figure 8. Myosin heavy chain protein content and ratio of myosin heavy chain I to
myosin heavy chain II after chronic maternal inflammation. Electrophoretic mobility
was used to separate MyHC-I and MyHC II fractions of total protein isolated from
fetal extensor digitorum longus muscle.
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Chapter 3

Metabolic response of bovine myoblasts exposed to sustained β adrenergic agonist
stimulation during in vitro differentiation

Abstract. The β adrenergic agonists ractopamine HCl (β1) and zilpaterol HCl (β2) are
commonly used as feed additives in finishing livestock to increase muscle deposition and
decrease adipose accumulation, however the physiological mechanisms for these effects
remain unclear. Previous studies conducted in our lab show that in adult rat skeletal
muscle, acute stimulation with β2 agonist increases basal and insulin stimulated glucose
oxidation in skeletal muscle from adult rats and growing lambs (Barnes et al., 2017;
Cadaret et al., 2017b). Our objective was to determine the metabolic response of bovine
myoblasts (muscle stem cells) differentiated in the presence of β adrenergic agonists in
order to determine if the metabolic regulation by the β adrenergic system observed in
skeletal muscle is contributed by muscle stem cells. Glucose uptake and glucose
oxidation were determined in primary bovine myoblasts incubated for 4 days in
differentiation media (2% FBS) with or without insulin, β1 adrenergic agonist, or β2
adrenergic agonist. Incubation with insulin alone increased (P < 0.05) glucose uptake by
~40% and oxidation by ~68% when compared to basal incubations. β2 adrenergic agonist
alone likewise increased (P < 0.05) glucose uptake by ~54% and oxidation by ~49% from
basal to levels that did not differ from insulin alone. β1 adrenergic agonist alone did not
affect glucose uptake and only marginally increased (P < 0.05) glucose oxidation by
~18% from basal. Moreover, when β1 adrenergic agonist was combined with insulin,
glucose uptake and oxidation were less (P < 0.05) than with insulin alone. Surprisingly,
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when β2 adrenergic agonist was combined with insulin, glucose uptake was not different
from insulin alone but glucose oxidation was decreased (P < 0.05) compared to insulin
alone. Together, these findings show that β2 adrenergic agonists are more effective at
increasing metabolic efficiency in myoblasts than β1 adrenergic agonists, just as in
mature skeletal muscle. However, these findings also show that β2 adrenergic agonists do
not have the same effect on insulin-stimulated glucose oxidation in myoblasts as they do
in mature muscle, indicating that the entire metabolic phenotype of mature muscle is not
derived from the muscle stem cells, and that key aspects of adrenergic regulation of
glucose metabolism appear to develop within the fibers themselves.
Introduction
β adrenergic agonists, ractopamine HCl and zilpaterol HCl, sold under the trade
names Optaflexx and Zilmax, respectively, enhance muscle growth and decrease fat
accumulation in finishing cattle when used as feed additives (Mersmann, 1998). Pressure
to increase feed efficiency due to a growing population, an increase in beef consumption,
and competition for available land makes it beneficial for producers to use these products.
This allows fewer resources and animals to yield more meat (Strydom, 2016) which
benefits the U.S. agriculture economy (Centner et al., 2014). Zilpaterol HCl acts via β2
receptors and ractopamine HCl acts primarily via β1 receptors (Lean et al., 2014). We
have recently shown that β2 adrenergic agonists enhance metabolic efficiency by
increasing glucose oxidation in skeletal muscle (Cadaret et al., 2017b). However, it is
important to know whether these effects originate within muscle stem cells that will
ultimately fuse with skeletal muscle fibers or whether they originate within the mature
fibers themselves. After birth, skeletal muscle grows by incorporating muscle stem cells
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called myoblasts (Schultz, 1989; Allen and Rankin, 1990). Myoblasts increase the
myonuclear content of skeletal muscle fibers after they are activated from their quiescent
state to proliferate, differentiate, and fuse with existing muscle fibers (Allen and
Boxhorn, 1989; Grounds and Yablonka-Reuveni, 1993). In fact, 50-99% of a muscle
fiber’s myonuclear content originates from myoblasts incorporated after the fiber is
formed (Allen et al., 1979), thus myoblasts contribute greatly to the metabolic phenotype
of the muscle. We recently found that skeletal muscle from mature rats and growing
lambs exposed to β2 adrenergic agonist acutely and chronically, respectively, had
increased insulin-stimulated glucose oxidation rates in culture (Barnes et al., 2017;
Cadaret et al., 2017b). Since skeletal muscle development stems in large part from fusion
of myoblasts, we hypothesize that this metabolic phenotype is inherited from the muscle
stem cells via fusion with mature muscle fibers. Furthermore, differentiation of myoblasts
in the presence of β agonists may also affect their responsiveness to β stimulation.
Materials and Methods
Animals. The following experiments were approved by the Institutional Animal
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by
the American Association for Accreditation of Laboratory Animal Care. Animals used
for this study included four Angus-cross steers approximately one year of age that were
humanely harvested at the UNL abattoir.
Myoblast Isolation. At harvest, 500g of fresh semitendinosus muscle was cleaned
of all connective tissue and fat and finely minced. Minced muscle was placed in 50 ml
conical tubes, washed with ice-cold phosphate buffered saline (PBS, Fisher Bioreagents),
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and centrifuged at 1,500 x g for 5 minutes at 4ºC. Pelleted tissue was re-suspended in
PBS, and digested with protease type XIV from Strept. griseus (Sigma) at a concentration
of 625 mg/500 ml at 37ºC for 1 hour, and centrifuged at 1,500 x g for 5 minutes. Digested
pellets were re-suspended in warm PBS and centrifuged at 500 x g for 10, 8, and 1
minute. After each spin, supernatant containing the myoblasts was collected, filtered,
pelleted, and re-suspended in DMEM media. Cells were incubated in pre-plate media
(DMEM with 10% FBS) at 37 ºC for 2 hours to remove fibroblasts. Myoblasts were
collected, pelleted, re-suspended in freezing media (DMEM with 20% FBS and 10%
dimethyl sulfoxide), slowly frozen, and stored in liquid nitrogen. All media constituents
were purchased from Sigma-Aldrich except insulin, which was purchased from Eli Lilly.
Cell Culture. Bovine myoblasts were seeded onto 12-well fibronectin-coated
tissue culture plates for glucose uptake studies and 6-well plates for glucose oxidation
studies at an initial seeding density of 20,000 cells per well for both studies. Cells were
grown as previously described (Yates et al., 2014) with some modifications. Briefly, all
plates were coated with Poly-L-Lysine and Bovine Plasma Fibronectin. Cells were
incubated in complete growth media (78.5% DMEM, 20% FBS, 1% Ab/Am, and 0.5%
Gentamicin) for 24 hours then incubated in differentiation media (96.5% DMEM, 2%
FBS, 1% Ab/Am, and 0.5% Gentamicin) for four days. Differentiation media was spiked
with one of the following treatments: no additive (basal), insulin (5 mU/ml HumulinR),
β1 agonist (1 µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist +
insulin, or β2 agonist + insulin (Figure 1). Differentiation media was changed every other
day. After four days, glucose uptake and oxidation studies were performed.
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Glucose Uptake. Cells were pre-incubated at 37ºC for 1 hour in treatment spiked
Krebs-Henseleit Buffer (KHB) media containing 0.1% BSA, 5mM glucose, and 35 mM
mannitol and then washed at 37ºC for 20 minutes in treatment-spiked glucose-free KHB
media with 0.1% BSA and 40 mM mannitol. Finally, cells were incubated at 37º C for 20
minutes in treatment-spiked KHB media with 1 mM [3H] 2-deoxyglucose (3,000 μCi/mmol)
and 39 mM [U-14C] mannitol (12.5 µCi/mmol), and 0.1% BSA. Media was then removed and

cells were thrice washed with sterile saline. Cultures were fixed with 4% PFA (SigmaAldrich) for 20 minutes. then washed with sterile saline. Cells were nuclear stained with
5 µg/ml Hoeshst 3342 (Thermo-Fischer) diluted in sterile saline (Vet One, Boise, Idaho).
Cell number was estimated for each well using Olympus CellSense Software from 3
random fields of view (area = 1.4 x 1.0 mm.). The average number of cells per field of
view was 580. After images were captured, cells were lysed with 2 mM NaOH and lysate
were transferred to 20 ml scintillation vials and mixed with UltimaGold scintillation
fluid. Specific activity of [3H] in each lysate was used to estimate glucose uptake, and
specific activity of [14C] in each lysate was used to estimate extracellular fluid volume
using a Beckman-Coulter 1900 TA LC counter (Brea, CA). Specific activity of [3H] 2deoxyglucose in media was determined from three 10-µl aliquots mixed with 500-µl

double-distilled water. All radioactive materials and scintillation fluids were purchased
from Perkin-Elmer (Waltham, MA). Four technical replications per condition were
performed and averaged for each animal.
Glucose Oxidation. Myoblasts plated on one side of sealable dual-well chambers
were used to determine glucose oxidation. Wells were imaged using Olympus CellSense
Software just before beginning the study. Three bright-field images per well were used to
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estimate the number of cells per well. Cells were pre-incubated at 37ºC for 1 hour in
treatment-spiked KHB media containing 0.1% BSA and 5 mM glucose and then washed
at 37ºC for 20 minutes in glucose-free treatment-spiked KHB media containing 0.1%
BSA. Chambers were then sealed using greased rubber gaskets and cells were incubated
at 37º C for 2 hours in treatment-spiked gassed (95% O2: 5% CO2) KHB media and
containing 5 mM [14C-U] D-glucose (2.5 µCi/mmol) and 0.1% BSA. In the adjacent well
of each sealed chamber, 2 mM NaOH was placed to capture CO2 produced. After the
incubation period, plates were cooled for 2 minutes at -20ºC, 2M HCl was injected into
the media through the rubber seal to release bicarbonate-bound CO2 from media and
plates were incubated at 4ºC for 1 hour. Chambers were then opened and NaOH was
collected and mixed with UltimaGold scintillation fluid in a 20-ml scintillation vial.
Specific activity of 14CO2 and media were determined as described above. Background
was determined from no-cell control chambers, and leak tests were performed by
measuring 14CO2 in NaOH placed in adjacent chambers. Three technical replications per
condition were averaged for each animal.
Statistical Analysis. Data were analyzed by ANOVA using the GLM procedure of
SAS (SAS Institute, Cary, NC). Steer was the experimental unit (n=4). Rates were
normalized to cell number and are expressed as percentage of basal rate (mean ± standard
error). The mean for each experimental unit is the average of four and three technical
replications for glucose uptake and glucose oxidation, respectively. Cell numbers were
estimated from a minimum of 133 cells per well counted over a minimum of three
random non-overlapping fields of view.
Results
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Glucose Uptake. Incubation of myoblasts with insulin alone increased (P < 0.05)
glucose uptake by ~40% compared to basal incubations (Figure 2). Incubation with β2
adrenergic agonist alone also increased (P < 0.05) glucose uptake by ~54% compared to
basal. Conversely, incubation with β1 adrenergic agonist alone had no effect on glucose
uptake compared to basal. Furthermore, glucose uptake in myoblasts that were coincubated with β1 adrenergic agonist and insulin or with β2 adrenergic agonist and
insulin was not different from myoblasts incubated with insulin alone.
Glucose Oxidation. Incubation of myoblasts with insulin alone increased (P <
0.05) glucose oxidation by ~68% compared to basal (Figure 3). Incubation with β2
adrenergic agonist alone also increased (P < 0.05) glucose oxidation by ~49% when
compared to basal. Conversely, incubation with β1 adrenergic agonist alone had no effect
on glucose oxidation. Furthermore, co-incubation with insulin and β1 agonist or with
insulin and β2 agonist decreased glucose oxidation when compared to insulin alone.
Incubation with β2 agonist alone increased glucose oxidation when compared to
incubation with β1 agonist alone. In addition, co-incubation with insulin and β1 agonist
was no different than co-incubation with insulin and β2 agonist.
Discussion
In this study, we show that glucose uptake and oxidation rates are increased when
myoblasts are differentiated in the presence of β2 adrenergic stimulation when compared
to β1 adrenergic stimulation or no stimulation. This indicates that β2-specific adrenergic
activity increases glucose metabolic efficiency in differentiated myoblasts similar to its
effects in skeletal muscle. Conversely, β2 adrenergic stimulation reduced insulinstimulated glucose oxidation rates, which is opposite of the effect on skeletal muscle
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during acute stimulation (Cadaret et al., 2017b). This indicates that the interaction
between insulin and β agonists is different in myoblasts after sustained exposure during
differentiation than it ultimately is in the mature fibers themselves. This difference could
be due to sensitivity differences that exist between myoblasts and skeletal muscle or due
to changes brought on by the longer exposure time in the present study.
Stimulation by β2 adrenergic agonist alone increased metabolic efficiency in
myoblasts when compared to stimulation by β1 adrenergic agonist alone. We postulate
that this is due to differences in metabolic pathways affected by each of these adrenergic
agonists. Glucose oxidation was increased in myoblasts stimulated with the β2 adrenergic
agonist, however, glucose oxidation was not affected by the β1 adrenergic agonist. This
suggests that the β1 adrenergic agonist does not stimulate glucose oxidation and thus may
be stimulating other metabolic pathways such as fatty acid mobilization in order to
contribute to skeletal muscle gain efficiency observed in feedlot animals
In bovine myoblasts, β2 adrenergic stimulation decreased insulin-stimulated
metabolic efficiency. However, stimulation of adult rat skeletal muscle with β2
adrenergic agonists and insulin increased insulin-stimulated metabolic efficiency
(Cadaret et al., 2017b). This indicates that β2 agonist and insulin interactions in mature
muscle fibers are not necessarily derived from the muscle stem cells. Furthermore, it is
also important to note that the bovine myoblasts were chronically exposed to the β
adrenergic stimulation since they were differentiated for 4 days in treatment-spiked
media, whereas the adult rat skeletal muscle had only been acutely exposed (~4 hours) to
the β adrenergic agonists. This could indicate that chronic exposure desensitizes β2
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adrenergic receptors in differentiating myoblasts, thus contributing to the decrease in
insulin-stimulated glucose oxidation.
Differentiation of myoblasts in the presence of β1 adrenergic agonist, had no
effect on either glucose uptake or oxidation rates. This indicates that the β1 adrenergic
agonist functions through different metabolic pathways than β2 adrenergic agonist to
enhance muscle development and decrease lipid accumulation which may or may not
involve changes in metabolic efficiency. However, β1 adrenergic stimulation reduced the
ability of insulin to stimulate glucose oxidation. Chronic exposure to epinephrine is
known to decrease insulin sensitivity (Deibert and Defronzo, 1980), and our findings
would indicate that this is primarily due to β1 specific activity. Together, our findings
demonstrate that zilpaterol HCl is more effective at increasing metabolic efficiency
compared to ractopamine HCl, and that the beneficial effects of ractopamine HCl on
muscle growth efficiency occur through some other physiological mechanism.
In conclusion, our study shows similarities as well as notable differences in
responsiveness to β adrenergic stimulation between differentiated myoblasts and mature
skeletal muscle. Most notably, β2 adrenergic stimulation had opposite effects on insulinstimulated glucose oxidation in differentiated myoblasts in the present study as
previously observed in mature skeletal muscle. This indicates that these interacting
regulatory responses develop in the mature fiber and are not necessarily a phenotypic trait
derived from muscle stem cells during fusion. Nevertheless, β2-stimulated glucose
oxidation in our differentiated myoblasts paralleled stimulation in mature skeletal muscle,
and β1 adrenergic stimulation had little to no effect on myoblasts, similar to our previous
observations in skeletal muscle.
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Figure 1. Components of differentiation media for bovine myoblasts.
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Figure 2. Schematic of glucose uptake study (A) and results of glucose uptake (B) in
primary bovine myoblasts during 20 minute incubation after differentiation with one
of the following treatments: No additive (basal), insulin (5 mU/ml HumulinR), β1
agonist (1 µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist +
insulin, or β2 agonist + insulin. a,b,c means with different superscripts differ (P ≤ 0.05).
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Figure 3. Schematic of glucose oxidation study (A) and results of glucose oxidation
(B) in bovine myoblasts during a 120 minute incubation after differentiation with the
following treatments: No additive (basal), insulin (5 mU/ml HumulinR), β1 agonist (1
µM ractopamine HCl), β2 agonist (0.05 µM zilpaterol HCl), β1 agonist + insulin, or
β2 agonist + insulin. a,b,c,d means with different superscripts differ (P ≤ 0.05).

55

Chapter 4
Oxidative capacity in myoblasts from high and low androstenedione cows

Abstract. Calves born to cows classified as having elevated follicular fluid
concentrations of androstenedione (A4; High A4) have increased weaning weights
compared to control Low A4 cows. However, the underlying mechanisms causing the
increased weaning weights in calves born to High A4 cows is unknown. Our objective
was to determine whether myoblasts isolated from High A4 cows had increased
metabolic efficiency compared to myoblasts from Low A4 cows, which may help to
explain the increase in weight gain in calves born to High A4 cows. For this study,
myoblasts were isolated from the oblique of ten composite beef cows that were classified
as having High (n=5; A4 ≥ 40 ng/ml) or Low (n=5; A4 ≤ 20 ng/ml) A4 concentrations.
Myoblasts were incubated in complete growth media for 48 hours then incubated in
treatment-spiked XF base medium containing either no additive (basal), 1 mU/ml insulin,
or 10 mU/ml insulin. A mitochondrial stress test was performed on the myoblast cultures
to measure oxygen consumption rate (OCR) as a proxy for mitochondrial respiration and
extra-cellular acidification rate (ECAR) as a proxy for glycolysis. Serial injection of
Oligomycin, FCCP, and Rotenone were utilized during the mitochondrial stress test to
uncouple mitochondrial oxygen consumption and inhibit ATP production. This study
showed no differences in mitochondrial respiration among A4 groups but a tendency for
greater (P = 0.1) glycolysis in High A4 myoblasts incubated in basal conditions and in
Low A4 myoblasts incubated with 1 mU/ml insulin. Moreover, OCR for basal respiration
and for ATP production were greatest (P < 0.05) in the absence of insulin and were
reduced similarly by 1 and 10 mU/ml insulin. Together, these results show that the
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greater weaning weights in the High A4 population do not appear to be due to greater
muscle metabolic efficiency.
Introduction
A population of cows within the University of Nebraska-Lincoln herd were
classified as having high androstendione (A4) concentrations within their follicular fluid
(Summers et al., 2014). Elevated concentrations of androgens is a hallmark of polycystic
ovary syndrome (PCOS), which is known to decrease fertility rates (Franks, 2006). In
fact, the cows identified as having High A4 concentrations had a 17% reduction in
calving rates (Summers et al., 2014). Furthermore, elevated maternal androgen levels
during gestation are known to impair fetal growth, leading to reduced birth weight
(Carlsen et al., 2006), and lead to metabolic deficiencies into adult life (Smith et al.,
2009). Interestingly, calves that were born to cows classified as having High A4
concentrations had greater weaning weights than calves born to Low A4 cows by 12 kg.
(Summers et al., 2014). This indicates that metabolic adaptations to the physiological
state of High A4 cows may be occurring during gestation. In addition to decreased
fertility rates, a well characterized factor seen in patients with PCOS is altered
metabolism leading to insulin resistance and obesity (Dunaif et al., 1989; Legro, 2000).
We speculate that A4 may be acting in one of two ways. First, A4 may stimulate similar
anabolic effects as testosterone, leading to an increase in skeletal muscle mass in the
growing calf. Secondly, A4 may antagonize the effects of testosterone, and chronic in
utero exposure to a High A4 environment may lead to a desensitization of skeletal muscle
to A4, thus reducing its antagonist effect.
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The mitochondrial electron transport chain consists of a series of redox reactions
that reduce NADH using oxygen to form H2O and ATP (Turrens and Boveris, 1980).
There are 4 complexes within the electron transport chain in addition to an ATP synthase
complex (Zhang et al., 1990). During a mitochondrial stress test, different compounds
including Oligomycin, FCCP, and Rotenone are introduced into a cell culture
sequentially to shut down complexes in the electron transport chain in order to measure
specific components of oxygen consumption rate (OCR) (Figure1). Injection of
Oligomycin into media blocks ATP synthesis by shutting down the ATP synthase
complex of the electron transport chain (Nicholls et al., 2010). Consequentially, oxygen
is maximally consumed by Complex IV. By measuring OCR before and after Oligomycin
has been injected, the fraction of oxygen consumed during ATP synthesis and fraction
needed to overcome proton leak can be determined. The second compound injected into
the media is FCCP which uncouples ATP production, leading to rapid energy and oxygen
consumption without the production of ATP. Thus, OCR and extra-cellular acidification
rate (ECAR) increase because the cell will attempt to maintain energy balance by
utilizing glycolysis for ATP generation. The last compound to be injected during the
study is Rotenone, which inhibits Complex I. This shuts down the electron transport
chain, inhibiting mitochondrial respiration and allowing both mitochondrial and nonmitochondrial fractions that contribute to respiration to be measured (Nicholls et al.,
2010). By measuring OCR after each compound is added, cellular oxidation of total
substrates (amino acids, lipids, and carbohydrates) can be determined. Furthermore,
measurement of ECAR allows cellular glycolysis to be measured. The objective of this
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study was to determine whether the increased weaning weights of the calves born to High
A4 cows is a result of increased muscle metabolic efficiency in this population.
Materials and Methods
Animals. The following experiments were approved by the Institutional Animal
Care and Use Committee at the University of Nebraska-Lincoln. Studies were conducted
at the University of Nebraska-Lincoln Animal Science Complex which is accredited by
the American Association for Accreditation of Laboratory Animal Care. Animals used
for this study included ten composite beef cows [25% MARC III (25% Angus, 25%
Hereford, 25% Pinzgauer, 25% Red Poll)].
Androstenedione Classification. Follicular fluid A4 concentrations were
determined as previously described (Summers et al., 2014). Follicular fluid A4
concentrations were determined using a human A4 ELISA kit (Alpha Diagnostics
International, San Antonio, TX). Inter- and intra- assay of variation for A4 coefficients
were 6.5% and 5.7% respectively. The cows were classified as High (≥ 40 ng/ml A4) or
Low (≤ 20 ng/ml) A4 based on dominant A4 concentration for follicle aspiration at
ovariectomy procedures.
Myoblast Isolation. During ovariectomy, muscle from the oblique was collected
and cleaned of all connective tissue and fat, and then finely minced. Minced muscle was
placed 50 ml conical tubes, washed with ice-cold phosphate buffered saline (PBS, Fischer
Bioreagents) and centrifuged at 1,500 x g for 5 minutes. Pelleted tissue was re-suspended
in PBS, digested with protease type XIV from Strept. griseus (Sigma) at a concentration
of 625 mg/500 ml PBS at 37ºC for 1 hour, and centrifuged at 1,500 x g for 5 minutes.
Digested pellets were re-suspended in warm PBS and centrifuged 3 times at 500 x g for
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10, 8, and 1 minute. Supernatant containing myoblasts was collected after each spin.
These cells were incubated at 37ºC in pre-plate media (DMEM with 10% FBS) for 2
hours to remove fibroblasts. Cells were then re-suspended in freezing media (CGM +
10% dimethyl sulfoxide) and stored in liquid nitrogen. All media constituents were
purchased from Sigma-Aldrich except insulin, which was purchased from Eli Lilly.
Cell Culture. Isolated bovine myoblasts were seeded onto 24-well XFe24 Cell
Culture Microplates (Seahorse Bioscience, North Billerica, MA) at an initial seeding
density of 5,000 cells per well. Four background correction wells were seeded with no
cells. Cells were grown as previously described (Yates et al., 2014) with some
modifications. Briefly, all plates were coated with Poly-L-Lysine and Bovine Plasma
Fibronectin. Cells were incubated at 37ºC and 5% CO2 in complete growth media (78.5%
DMEM, 20% FBS, 1% Ab/Am, and 0.5% Gentamicin) for 48 hours.
XF Assay Mito Stress Test. After 48 hour incubation in complete growth media,
cells were washed twice with XF Base Media (Seahorse Bioscience) containing 25 mM
glucose, 1.0 mM pyruvate, and 2 mM L-glutamine. The medium was then spiked with no
additive (basal), 1 mU/ml insulin (Humulin-R), or 10 mU/ml insulin. 500 µl of XF Base
Medium with the previously described additives were added to each well and cells were
incubated at 37ºC in a non-CO2 incubator for 1 hour. A cell mito stress test was run on
the plate using the Seahorse XF-96 instrument (Seahorse Bioscience). 1.0 µM
oligomycin, 1.0 µM FCCP, and 0.5 µM rotenone were sequentially injected to determine
ATP-linked respiration, maximal respiration, and non-mitochondrial respiration,
respectively. These parameters along with basal respiration were used to determine
proton leak and respiration capacity.
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BCA Protein Assay. Following the mito stress test, total protein of cells was
determined in each well using a Pierce BCA Protein Assay Kit (Thermo Fisher,
Waltham, MA). XF base media was aspirated from wells and 75 µl of RIPA buffer
(Thermo Fisher) was added to each well. A sterile p200 pipette tip was used to scrape
cells from the bottom of each well. 10 µl of each prepared serial dilution of albumin
standard and each sample were added in triplicates to a 96-well plate followed by 200 µl
of working solution. Plate was mixed thoroughly on a shaker for 30 seconds and
incubated at 37ºC for 30 minutes. Absorbance was then measured at 562 nm on an
EPOCH plate reader (Bio Tek, Winooski, VT) and analyzed using GEN5 software (Bio
Tek).
Statistical Analysis. Data were analyzed using ANOVA output of SAS (SAS
Institute, Cary, NC) as a 2x3 factorial. High vs. Low A4 was the main effect, and insulin
concentration and A4*insulin interaction was in the subplot interaction. Cow was the
experimental unit (N=10). The mean for each experimental unit is the average of 6
technical replications per insulin concentration for OCAR and ECAR. For each well,
OCR and ECAR were normalized to amount of total protein. Means for each
measurement period are the average of three measurements taken 5 minutes apart. Data
are presented as means ± standard error.
Results
For this study, OCR (Figure 2) was measured in bovine myoblasts. There were
not differences among A4 groups for basal respiration rate, ATP production, or maximal
ATP production for OCR (Figure 3). Similarly, there were not differences among A4
groups for any measurements taken after each inhibitory compound was injected into the
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media for OCR. In addition, ECAR (Figure 4) was measured and there were not
differences among A4 groups for glycolytic capacity (Figure 5). However, the myoblasts
from High A4 cows incubated at basal and Low A4 cows incubated with 1 mU/ml of
insulin tended to have increased (P = 0.1) glycolysis after injection of Oligomycin. There
were no differences among treatments for any other measurements taken after FCCP or
Rotenone were injected into the media for ECAR.
Discussion
In this study, we did not find any differences in OCR between myoblasts isolated
from High A4 and Low A4 cows, suggesting that mitochondrial respiration and thus ATP
production from oxidation is similar between High and Low A4 cows. Furthermore,
myoblasts from High A4 cows in the absence of insulin and myoblasts from Low A4
cows in the presence of insulin had a tendency for increased glycolytic rates.
The OCR between the High and Low A4 cows was similar, indicating that
cellular oxygen consumption rate among treatments was not different. Since oxygen is
being consumed at a similar rate among treatments, it suggests that carbohydrates, amino
acids, and lipids are being oxidized at similar rates. Furthermore, the addition of
inhibitory compounds such as Oligomycin, FCCP, and Rotinone had similar affects
among treatments which also suggests that oxidation rates are not different among
groups. Adaptations occurring during gestation or other growth advantages that lead to
increased weaning weights in High A4 cattle populations are likely not derived from
enhanced metabolic efficiency in muscle from the cow.
A major role of insulin in metabolism is to stimulate uptake of glucose into cells
where it can be metabolized by one of several pathways, including anaerobic glycolysis.
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The treatments had similar glycolytic capacities but myoblasts from High A4 cows in the
absence of insulin and Low A4 cows when insulin was present had a tendency for
increased glycolytic rates. This was determined by increased acidification in cell media
resulting from lactate production, a byproduct of glycolysis.
We hypothesized that myoblasts from the High A4 cows would have increased
metabolic efficiency compared to myoblasts from the Low A4 cows which would help to
explain greater pre-weaning growth in this population. However, we saw no differences
in skeletal muscle oxidative metabolic efficiency. This suggests that the increased
weaning weights seen in the calves from cows classified as High A4 is due to a different
molecular mechanism than postulated. However, additional studies that take a closer look
at the metabolic efficiency of the skeletal muscle from the calves themselves may help
clarify gaps in our understanding of the underlying mechanism that leads to their
increased weaning weights.
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Figure 1. Components of mitochondrial respiration (A). Oxygen consumption rate in
bovine myoblasts from High and Low A4 cows incubated with either basal, 1 mU/ml,
or 10 mU/ml of insulin. Each mean is the average of three measurements taken during
the period (B).
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Figure 3. Oxygen consumption for basal respiration (A), ATP production (B), and
ATP production normalized to basal (C) in bovine myoblasts from High and Low A4
cows incubated with either basal, 1 mM/ml, or 10 mM/ml of insulin.
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Figure 5. Glycolysis (A) and glycolytic capacity (B) in bovine myoblasts from High and

Low A4 cows incubated with either basal, 1 mU/ml, or 10 mU/ml of insulin. *Means
tend to differ (P ≤ 0.10) between A4 groups within insulin concentrations.

67

References
Abbott, D., D. Barnett, C. Bruns, and D. Dumesic. 2005. Androgen excess fetal
programming of female reproduction: a developmental aetiology for polycystic
ovary syndrome? Human reproduction update 11: 357-374.
Abel, E. D. et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin
action in muscle and liver. Nature 409: 729-733.
Alisi, A., N. Panera, C. Agostoni, and V. Nobili. 2011. Intrauterine growth retardation
and nonalcoholic Fatty liver disease in children. International journal of
endocrinology 2011.
Allen, R. E., and L. K. Boxhorn. 1989. Regulation of skeletal muscle satellite cell
proliferation and differentiation by transforming growth factor‐ beta, insulin‐ like
growth factor I, and fibroblast growth factor. Journal of cellular physiology 138:
311-315.
Allen, R. E., R. A. Merkel, and R. B. Young. 1979. Cellular aspect of muscle growth:
myogenic cell proliferation. Journal of Animal Science 49: 115-127.
Allen, R. E., and L. L. Rankin. 1990. Regulation of satellite cells during skeletal muscle
growth and development. Proceedings of the Society for Experimental Biology
and Medicine 194: 81-86.
Andersen, H. J., N. Oksbjerg, J. F. Young, and M. Therkildsen. 2005. Feeding and meat
quality–a future approach. Meat science 70: 543-554.
Barker, D. J. et al. 1993. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension
and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia
36: 62-67.
Barker, D. J., K. L. Thornburg, C. Osmond, E. Kajantie, and J. G. Eriksson. 2010. The
surface area of the placenta and hypertension in the offspring in later life. The
International journal of developmental biology 54: 525.
Barker, D. J. P. 1998. Mothers, babies, and health in later life. Elsevier Health Sciences.
Barnes, T. L. et al. 2017. Identifying hyperthermia in heat-stressed lambs and its effects
on β agonist–stimulated glucose oxidation in muscle. ASAS Western Section:
106.
Barry, J. S., and R. V. Anthony. 2008. The pregnant sheep as a model for human
pregnancy. Theriogenology 69: 55-67.
Bartha, J. L., R. Romero‐ Carmona, and R. Comino‐ Delgado. 2003. Inflammatory
cytokines in intrauterine growth retardation. Acta obstetricia et gynecologica
Scandinavica 82: 1099-1102.
Bauer, M. et al. 1998. Fetal growth and placental function. Molecular and cellular
endocrinology 140: 115-120.
Bell, A., R. Wilkening, and G. Meschia. 1987. Some aspects of placental function in
chronically heat-stressed ewes. Journal of developmental physiology 9: 17-29.
Brodsky, D., and H. Christou. 2004. Current concepts in intrauterine growth restriction.
Journal of Intensive Care Medicine 19: 307-319.
Brown, L. D. 2014. Endocrine regulation of fetal skeletal muscle growth: impact on
future metabolic health. Journal of Endocrinology 221: R13-R29.

68

Brown, L. D. et al. 2015. Limited capacity for glucose oxidation in fetal sheep with
intrauterine growth restriction. American Journal of Physiology-Regulatory,
Integrative and Comparative Physiology 309: R920-R928.
Cadaret, C. N. et al. 2017a. Maternal inflammation at mid-gestation in pregnant rats
impairs fetal muscle growth & development at term. ASAS Western Section: 213.
Cadaret, C. N., K. A. Beede, H. E. Riley, and D. T. Yates. 2017b. Acute exposure of
primary rat soleus muscle to zilpaterol HCl (β2 adrenergic agonist), TNFα, or IL6 in culture increases glucose oxidation rates independent of the impact on insulin
signaling or glucose uptake. Cytokine 96: 107-113.
Cantor, B., T. Tyler, R. Nelson, and G. Stein. 1980. Oligohydramnios and transient
neonatal anuria: a possible association with the maternal use of prostaglandin
synthetase inhibitors. The Journal of reproductive medicine 24: 220-223.
Carlsen, S., G. Jacobsen, and P. Romundstad. 2006. Maternal testosterone levels during
pregnancy are associated with offspring size at birth. European Journal of
Endocrinology 155: 365-370.
Cefalu, W. T. 2001. Insulin resistance: cellular and clinical concepts. Experimental
biology and medicine 226: 13-26.
Centner, T., J. Alvey, and A. Stelzleni. 2014. Beta agonists in livestock feed: Status,
health concerns, and international trade. Journal of animal science 92: 4234-4240.
Chiswick, M. L. 1985. Intrauterine growth retardation. British medical journal (Clinical
research ed.) 291: 845.
Cotechini, T., W. Hopman, and C. Graham. 2014. Inflammation-induced fetal growth
restriction in rats is associated with altered placental morphometrics. Placenta 35:
575-581.
Dandona, P., A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg. 2005. Metabolic
syndrome a comprehensive perspective based on interactions between obesity,
diabetes, and inflammation. Circulation 111: 1448-1454.
De Blasio, M. J., K. L. Gatford, J. S. Robinson, and J. A. Owens. 2007. Placental
restriction of fetal growth reduces size at birth and alters postnatal growth,
feeding activity, and adiposity in the young lamb. American Journal of
Physiology-Regulatory, Integrative and Comparative Physiology 292: R875R886.
DeFronzo, R. et al. 1981. The effect of insulin on the disposal of intravenous glucose:
results from indirect calorimetry and hepatic and femoral venous catheterization.
Diabetes 30: 1000-1007.
Deibert, D. C., and R. A. Defronzo. 1980. Epinephrine-induced insulin resistance in man.
Journal of Clinical Investigation 65: 717.
Dionne, M. S., L. N. Pham, M. Shirasu-Hiza, and D. S. Schneider. 2006. Akt and FOXO
dysregulation contribute to infection-induced wasting in Drosophila. Current
Biology 16: 1977-1985.
Dulloo, A. G. 2008. Thrifty energy metabolism in catch-up growth trajectories to insulin
and leptin resistance. Best practice & research Clinical endocrinology &
metabolism 22: 155-171.
Dunaif, A., K. R. Segal, W. Futterweit, and A. Dobrjansky. 1989. Profound peripheral
insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes
38: 1165-1174.

69

Dunlop, K., M. Cedrone, J. F. Staples, and T. R. Regnault. 2015. Altered Fetal Skeletal
Muscle Nutrient Metabolism Following an Adverse In Utero Environment and the
Modulation of Later Life Insulin Sensitivity. Nutrients 7: 1202-1216.
Duvnjak, L., T. Bulum, and Z. Metelko. 2008. Hypertension and the metabolic syndrome.
Diabetologia Croatica 37: 83-89.
Edmondson, D. G., and E. N. Olson. 1989. A gene with homology to the myc similarity
region of MyoD1 is expressed during myogenesis and is sufficient to activate the
muscle differentiation program. Genes & development 3: 628-640.
Eisner, J. R., D. A. Dumesic, J. W. Kemnitz, and D. H. Abbott. 2000. Timing of prenatal
androgen excess determines differential impairment in insulin secretion and
action in adult female rhesus monkeys. The Journal of Clinical Endocrinology &
Metabolism 85: 1206-1210.
Faloia, E. et al. 2004. Body composition, fat distribution and metabolic characteristics in
lean and obese women with polycystic ovary syndrome. Journal of
endocrinological investigation 27: 424-429.
Franks, S. 1995. Polycystic ovary syndrome. N Engl j med 1995: 853-861.
Franks, S. 2006. Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam
criteria. The Journal of Clinical Endocrinology & Metabolism 91: 786-789.
Galan, H. L. et al. 1999. Relationship of fetal growth to duration of heat stress in an ovine
model of placental insufficiency. American journal of obstetrics and gynecology
180: 1278-1282.
Gallagher, E. J., D. LeRoith, and E. Karnieli. 2011. The metabolic syndrome—from
insulin resistance to obesity and diabetes. Medical Clinics of North America 95:
855-873.
Gatford, K., R. Simmons, M. De Blasio, J. Robinson, and J. Owens. 2010. Review:
placental programming of postnatal diabetes and impaired insulin action after
IUGR. Placenta 31: S60-S65.
Gillespie, M. A. et al. 2009. p38-γ–dependent gene silencing restricts entry into the
myogenic differentiation program. The Journal of cell biology 187: 991-1005.
Gluckman, P. D., and M. A. Hanson. 2004. Living with the past: evolution, development,
and patterns of disease. Science 305: 1733-1736.
Green, A. S. et al. 2011. Characterization of glucose-insulin responsiveness and impact of
fetal number and sex difference on insulin response in the sheep fetus. American
Journal of Physiology-Endocrinology and Metabolism 300: E817-E823.
Greenwood, P., and A. Bell. 2002. Consequences of intra-uterine growth retardation for
postnatal growth, metabolism and pathophysiology. Reproduction (Cambridge,
England) Supplement 61: 195-206.
Grounds, M. D., and Z. Yablonka-Reuveni. 1993. Molecular and cell biology of skeletal
muscle regeneration Molecular and cell biology of muscular dystrophy. p 210256. Springer.
Grundy, S. M. 2000. Metabolic complications of obesity. Endocrine 13: 155-165.
Hales, C. et al. 1991. Fetal and infant growth and impaired glucose tolerance at age 64.
Bmj 303: 1019-1022.
Hales, C. N., and D. J. Barker. 1992. Type 2 (non-insulin-dependent) diabetes mellitus:
the thrifty phenotype hypothesis. Diabetologia 35: 595-601.

70

Hales, C. N., and D. J. Barker. 2001. The thrifty phenotype hypothesis. British medical
bulletin 60: 5-20.
Hay, W. W. 2006. Recent observations on the regulation of fetal metabolism by glucose.
The Journal of physiology 572: 17-24.
Heinig, J. et al. 2000. Determination of cytokine mRNA-expression in term human
placenta of patients with gestational hypertension, intrauterine growth retardation
and gestational diabetes mellitus using polymerase chain reaction. Zentralblatt für
Gynäkologie 122: 413-418.
Holcberg, G. et al. 2001. Increased production of tumor necrosis factor-α TNF-α by
IUGR human placentae. European Journal of Obstetrics & Gynecology and
Reproductive Biology 94: 69-72.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose Expression of
Tumor Necrosis Factor- : Direct Role in Obesity-Linked Insulin Resistance.
SCIENCE-NEW YORK THEN WASHINGTON- 259: 87-87.
Hutcheson, D. A., J. Zhao, A. Merrell, M. Haldar, and G. Kardon. 2009. Embryonic and
fetal limb myogenic cells are derived from developmentally distinct progenitors
and have different requirements for β-catenin. Genes & development 23: 9971013.
Inskip, H. et al. 2007. Size at birth and its relation to muscle strength in young adult
women. Journal of internal medicine 262: 368-374.
Irshad, A. et al. 2013. Factors influencing carcass composition of livestock: A review. J.
Anim. Prod. Adv 3: 177-186.
James, D. E., R. Brown, J. Navarro, and P. F. Pilch. 1988. Insulin-regulatable tissues
express a unique insulin-sensitive glucose transport protein.
Jones, C., and J. Ritchie. 1978. The metabolic and endocrine effects of circulating
catecholamines in fetal sheep. The Journal of physiology 285: 395-408.
Kitabchi, A. E., G. E. Umpierrez, J. M. Miles, and J. N. Fisher. 2009. Hyperglycemic
crises in adult patients with diabetes. Diabetes care 32: 1335-1343.
Klasing, K. C., and B. J. Johnstone. 1991. Monokines in growth and development.
Poultry Science 70: 1781-1789.
Klein, S. et al. 2007. Waist circumference and cardiometabolic risk: a consensus
statement from shaping America's health: Association for Weight Management
and Obesity Prevention; NAASO, the Obesity Society; the American Society for
Nutrition; and the American Diabetes Association. Obesity 15: 1061-1067.
Klip, A., and M. R. Pâquet. 1990. Glucose transport and glucose transporters in muscle
and their metabolic regulation. Diabetes care 13: 228-243.
Kupferminc, M. J., A. M. Peaceman, T. R. Wigton, K. A. Rehnberg, and M. L. Socol.
1994. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients
with severe preeclampsia. American journal of obstetrics and gynecology 170:
1752-1759.
L'honore, A. et al. 2007. Identification of a new hybrid serum response factor and
myocyte enhancer factor 2-binding element in MyoD enhancer required for
MyoD expression during myogenesis. Molecular biology of the cell 18: 19922001.
Law, C. et al. 2002. Fetal, infant, and childhood growth and adult blood pressure a
longitudinal study from birth to 22 years of age. Circulation 105: 1088-1092.

71

Lean, I. J., J. M. Thompson, and F. R. Dunshea. 2014. A meta-analysis of zilpaterol and
ractopamine effects on feedlot performance, carcass traits and shear strength of
meat in cattle. PloS one 9: e115904.
Legro, R. S. 2000. The genetics of obesity Lessons for polycystic ovary syndrome.
Annals of the New York Academy of Sciences 900: 193-202.
Leney, S. E., and J. M. Tavaré. 2009. The molecular basis of insulin-stimulated glucose
uptake: signalling, trafficking and potential drug targets. Journal of
Endocrinology 203: 1-18.
Leos, R. A. et al. 2010. Chronic exposure to elevated norepinephrine suppresses insulin
secretion in fetal sheep with placental insufficiency and intrauterine growth
restriction. American Journal of Physiology-Endocrinology and Metabolism 298:
E770-E778.
Li, D.-K., L. Liu, and R. Odouli. 2003. Exposure to non-steroidal anti-inflammatory
drugs during pregnancy and risk of miscarriage: population based cohort study.
Bmj 327: 368.
Lillioja, S. et al. 1987. Skeletal muscle capillary density and fiber type are possible
determinants of in vivo insulin resistance in man. Journal of Clinical Investigation
80: 415.
Limesand, S. W., P. J. Rozance, D. Smith, and W. W. Hay. 2007. Increased insulin
sensitivity and maintenance of glucose utilization rates in fetal sheep with
placental insufficiency and intrauterine growth restriction. American Journal of
Physiology-Endocrinology and Metabolism 293: E1716-E1725.
Maeda, T., and B. J. Koos. 2009. Adenosine A 1 and A 2a receptors modulate
insulinemia, glycemia, and lactatemia in fetal sheep. American Journal of
Physiology-Regulatory, Integrative and Comparative Physiology 296: R693R701.
Marconi, A. M., C. L. Paolini, G. Zerbe, and F. C. Battaglia. 2006. Lactacidemia in
intrauterine growth restricted (IUGR) pregnancies: relationship to clinical
severity, oxygenation and placental weight. Pediatric research 59: 570-574.
Marette, A., Y. Liu, and G. Sweeney. 2014. Skeletal muscle glucose metabolism and
inflammation in the development of the metabolic syndrome. Reviews in
Endocrine and Metabolic Disorders 15: 299-305.
Mersmann, H. J. 1998. Overview of the effects of beta-adrenergic receptor agonists on
animal growth including mechanisms of action. Journal of animal science 76:
160-172.
Molteni, R., S. Stys, and F. Battaglia. 1978. Relationship of fetal and placental weight in
human beings: fetal/placental weight ratios at various gestational ages and birth
weight distributions. The Journal of reproductive medicine 21: 327-334.
Morrison, J. L. 2008. Sheep models of intrauterine growth restriction: fetal adaptations
and consequences. Clinical and Experimental Pharmacology and Physiology 35:
730-743.
Nicholls, D. G. et al. 2010. Bioenergetic profile experiment using C2C12 myoblast cells.
Journal of visualized experiments: JoVE.
Østensen, M. 1996. Safety of non-steroidal anti-inflammatory drugs during pregnancy
and lactation. Inflammopharmacology 4: 31-41.

72

Ozanne, S. et al. 2005. Low birthweight is associated with specific changes in muscle
insulin-signalling protein expression. Diabetologia 48: 547-552.
Pickup, J., and M. Crook. 1998. Is type II diabetes mellitus a disease of the innate
immune system? Diabetologia 41: 1241-1248.
Pollack, R. N., and M. Y. Divon. 1992. Intrauterine growth retardation: definition,
classification, and etiology. Clinical obstetrics and gynecology 35: 99-107.
Reaven, G. M. 2005. The insulin resistance syndrome: definition and dietary approaches
to treatment. Annu. Rev. Nutr. 25: 391-406.
Regnault, T. et al. 2007. Development and mechanisms of fetal hypoxia in severe fetal
growth restriction. Placenta 28: 714-723.
Rinaudo, P., and E. Wang. 2012. Fetal programming and metabolic syndrome. Annual
review of physiology 74: 107.
Rumack, C. M. et al. 1981. Neonatal intracranial hemorrhage and maternal use of aspirin.
Obstet Gynecol 58: 52S-56S.
Saltiel, A. R., and C. R. Kahn. 2001. Insulin signalling and the regulation of glucose and
lipid metabolism. Nature 414: 799-806.
Schultz, E. 1989. Satellite cell behavior during skeletal muscle growth and regeneration.
Medicine and science in sports and exercise 21: S181-186.
Sir-Petermann, T. et al. 2002. Maternal serum androgens in pregnant women with
polycystic ovarian syndrome: possible implications in prenatal androgenization.
Human reproduction 17: 2573-2579.
Smith, P., T. L. Steckler, A. Veiga-Lopez, and V. Padmanabhan. 2009. Developmental
programming: differential effects of prenatal testosterone and dihydrotestosterone
on follicular recruitment, depletion of follicular reserve, and ovarian morphology
in sheep. Biology of reproduction 80: 726-736.
Späte, U., and P. C. Schulze. 2004. Proinflammatory cytokines and skeletal muscle.
Current Opinion in Clinical Nutrition & Metabolic Care 7: 265-269.
Spranger, J. et al. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes
results of the prospective population-based European Prospective Investigation
into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
Steckler, T., J. Wang, F. F. Bartol, S. K. Roy, and V. Padmanabhan. 2005. Fetal
programming: prenatal testosterone treatment causes intrauterine growth
retardation, reduces ovarian reserve and increases ovarian follicular recruitment.
Endocrinology 146: 3185-3193.
Strydom, P. 2016. Performance-enhancing technologies of beef production. Animal
Frontiers 6: 22-30.
Summers, A. F. et al. 2014. Altered theca and cumulus oocyte complex gene expression,
follicular arrest and reduced fertility in cows with dominant follicle follicular
fluid androgen excess. PloS one 9: e110683.
Turrens, J. F., and A. Boveris. 1980. Generation of superoxide anion by the NADH
dehydrogenase of bovine heart mitochondria. Biochemical Journal 191: 421-427.
Tuuli, M. G., A. Cahill, D. Stamilio, G. Macones, and A. O. Odibo. 2011. Comparative
efficiency of measures of early fetal growth restriction for predicting adverse
perinatal outcomes. Obstetrics & Gynecology 117: 1331-1340.

73

Uysal, K. T., S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil. 1997. Protection
from obesity-induced insulin resistance in mice lacking TNF-α function. Nature
389: 610-614.
Vaag, A. 2009. Low birth weight and early weight gain in the metabolic syndrome:
consequences for infant nutrition. International Journal of Gynecology &
Obstetrics 104: S32-S34.
Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996.
Suppression of TNF-alpha-induced apoptosis by NF-kB. Science 274: 787.
van Gelder, M. M., N. Roeleveld, and H. Nordeng. 2011. Exposure to non-steroidal antiinflammatory drugs during pregnancy and the risk of selected birth defects: a
prospective cohort study. PLoS One 6: e22174.
Van Itallie, T. B. 1985. Health implications of overweight and obesity in the United
States. Annals of internal medicine 103: 983-988.
Vonnahme, K. 2012. How the maternal environment impacts fetal and placental
development: implications for livestock production. Animal Reproduction 9: 789797.
Wilson, S., J. McEwan, P. Sheard, and A. Harris. 1992. Early stages of myogenesis in a
large mammal: formation of successive generations of myotubes in sheep tibialis
cranialis muscle. Journal of Muscle Research & Cell Motility 13: 534-550.
Wood, I. S., and P. Trayhurn. 2003. Glucose transporters (GLUT and SGLT): expanded
families of sugar transport proteins. British Journal of Nutrition 89: 3-9.
Yates, D. et al. 2012. Developmental programming in response to intrauterine growth
restriction impairs myoblast function and skeletal muscle metabolism. Journal of
pregnancy 2012.
Yates, D. T. et al. 2016. Intrauterine growth-restricted sheep fetuses exhibit smaller
hindlimb muscle fibers and lower proportions of insulin-sensitive Type I fibers
near term. American Journal of Physiology-Regulatory, Integrative and
Comparative Physiology 310: R1020-R1029.
Yates, D. T., X. Chen, and S. W. Limesand. 2011. Environmental heat stress impairs
placental function, fetal growth and development, and postnatal performance in
livestock. Environmental Physiology of Livestock: 209.
Yates, D. T. et al. 2014. Myoblasts from intrauterine growth‐ restricted sheep fetuses
exhibit intrinsic deficiencies in proliferation that contribute to smaller
semitendinosus myofibres. The Journal of physiology 592: 3113-3125.
Ylihärsilä, H. et al. 2007. Birth size, adult body composition and muscle strength in later
life. International journal of obesity 31: 1392-1399.
Zammit, P. S. et al. 2006. Pax7 and myogenic progression in skeletal muscle satellite
cells. Journal of cell science 119: 1824-1832.
Zhang, J.-M., and J. An. 2007. Cytokines, inflammation and pain. International
anesthesiology clinics 45: 27.
Zhang, Y., O. Marcillat, C. Giulivi, L. Ernster, and K. Davies. 1990. The oxidative
inactivation of mitochondrial electron transport chain components and ATPase.
Journal of Biological Chemistry 265: 16330-16336.
Zhu, M.-J., S. P. Ford, P. W. Nathanielsz, and M. Du. 2004. Effect of maternal nutrient
restriction in sheep on the development of fetal skeletal muscle. Biology of
reproduction 71: 1968-1973.

74

Zhu, M. J. et al. 2006. Maternal nutrient restriction affects properties of skeletal muscle
in offspring. The Journal of physiology 575: 241-250.

